174 related articles for article (PubMed ID: 17341467)
21. Cell-penetrating peptides: from molecular mechanisms to therapeutics.
Morris MC; Deshayes S; Heitz F; Divita G
Biol Cell; 2008 Apr; 100(4):201-17. PubMed ID: 18341479
[TBL] [Abstract][Full Text] [Related]
22. Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.
Resina S; Abes S; Turner JJ; Prevot P; Travo A; Clair P; Gait MJ; Thierry AR; Lebleu B
Int J Pharm; 2007 Nov; 344(1-2):96-102. PubMed ID: 17600642
[TBL] [Abstract][Full Text] [Related]
23. Peptide-based delivery of steric-block PNA oligonucleotides.
Abes S; Ivanova GD; Abes R; Arzumanov AA; Williams D; Owen D; Lebleu B; Gait MJ
Methods Mol Biol; 2009; 480():85-99. PubMed ID: 19085117
[TBL] [Abstract][Full Text] [Related]
24. Peptide-mediated delivery of nucleic acids into mammalian cells.
Deshayes S; Simeoni F; Morris MC; Divita G; Heitz F
Methods Mol Biol; 2007; 386():299-308. PubMed ID: 18604951
[TBL] [Abstract][Full Text] [Related]
25. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
26. PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery.
Qian Y; Zha Y; Feng B; Pang Z; Zhang B; Sun X; Ren J; Zhang C; Shao X; Zhang Q; Jiang X
Biomaterials; 2013 Mar; 34(8):2117-29. PubMed ID: 23245924
[TBL] [Abstract][Full Text] [Related]
27. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
[TBL] [Abstract][Full Text] [Related]
28. Activatable cell penetrating peptide-peptide nucleic acid conjugate via reduction of azobenzene PEG chains.
Lee SH; Moroz E; Castagner B; Leroux JC
J Am Chem Soc; 2014 Sep; 136(37):12868-71. PubMed ID: 25185512
[TBL] [Abstract][Full Text] [Related]
29. Cell number and transfection volume dependent peptide nucleic acid antisense activity by cationic delivery methods.
Llovera L; Berthold P; Nielsen PE; Shiraishi T
Artif DNA PNA XNA; 2012; 3(1):22-7. PubMed ID: 22679530
[TBL] [Abstract][Full Text] [Related]
30. Facile synthesis of peptide nucleic acids and peptide nucleic acid-peptide conjugates on an automated peptide synthesizer.
Joshi R; Jha D; Su W; Engelmann J
J Pept Sci; 2011 Jan; 17(1):8-13. PubMed ID: 20979047
[TBL] [Abstract][Full Text] [Related]
31. Bactericidal antisense effects of peptide-PNA conjugates.
Good L; Awasthi SK; Dryselius R; Larsson O; Nielsen PE
Nat Biotechnol; 2001 Apr; 19(4):360-4. PubMed ID: 11283595
[TBL] [Abstract][Full Text] [Related]
32. Cellular delivery and antisense effects of peptide nucleic acid conjugated to polyethyleneimine via disulfide linkers.
Berthold PR; Shiraishi T; Nielsen PE
Bioconjug Chem; 2010 Oct; 21(10):1933-8. PubMed ID: 20873710
[TBL] [Abstract][Full Text] [Related]
33. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Divita G
Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
[TBL] [Abstract][Full Text] [Related]
34. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
[TBL] [Abstract][Full Text] [Related]
35. A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system.
Zennami K; Yoshikawa K; Kondo E; Nakamura K; Upsilonamada Y; De Velasco MA; Tanaka M; Uemura H; Shimazui T; Akaza H; Saga S; Ueda R; Honda N
Oncol Rep; 2011 Aug; 26(2):327-33. PubMed ID: 21567093
[TBL] [Abstract][Full Text] [Related]
36. Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino.
Karkare S; Bhatnagar D
Appl Microbiol Biotechnol; 2006 Aug; 71(5):575-86. PubMed ID: 16683135
[TBL] [Abstract][Full Text] [Related]
37. Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells.
Shiraishi T; Hamzavi R; Nielsen PE
Nucleic Acids Res; 2008 Aug; 36(13):4424-32. PubMed ID: 18596083
[TBL] [Abstract][Full Text] [Related]
38. Targeted delivery of therapeutic oligonucleotides to pulmonary circulation.
Wilson A; He F; Li J; Ma Z; Pitt B; Li S
Adv Genet; 2005; 54():21-41. PubMed ID: 16096006
[TBL] [Abstract][Full Text] [Related]
39. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
Morris MC; Depollier J; Mery J; Heitz F; Divita G
Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
[TBL] [Abstract][Full Text] [Related]
40. Self-Assembling Lipid-Peptide Hybrid Nanoparticles of Phospholipid-Nonaarginine Conjugates for Enhanced Delivery of Nucleic Acid Therapeutics.
Kang JH; Battogtokh G; Ko YT
Biomacromolecules; 2017 Nov; 18(11):3733-3741. PubMed ID: 28954191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
